| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Vor Biopharma Inc.
13G/A
Amendment 2
VOR · 929033207
|
2.0% |
5/6/2026
Event 3/31/2026
|
|||
| Qiming Venture Partners VIII-HC, L.P. | 2.0% | ||||
| Qiming Venture Partners VIII Investments, LLC | 1.7% | ||||
| Qiming GP VIII, LLC | 1.7% | ||||
| Qiming GP VIII-HC, LLC | 2.0% | ||||
|
Vor Biopharma Inc.
13G/A
Amendment 1
VOR · 929033207
|
2.8% |
2/13/2026
Event 12/31/2025
|
|||
| Qiming Venture Partners VIII-HC, L.P. | 2.8% | ||||
| Qiming Venture Partners VIII Investments, LLC | 2.4% | ||||
| Qiming GP VIII, LLC | 2.4% | ||||
| Qiming GP VIII-HC, LLC | 2.8% | ||||
|
Vor Biopharma Inc.
13G
VOR · 929033207
|
5.4% |
11/5/2025
Event 9/18/2025
|
|||
| Qiming Venture Partners VIII Investments, LLC | 4.6% | ||||
| Qiming Venture Partners VIII-HC, L.P. | 5.4% | ||||
| Qiming GP VIII, LLC | 4.6% | ||||
| Qiming GP VIII-HC, LLC | 5.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.